Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 18034
Country/Region: Uganda
Year: 2017
Main Partner: The AIDS Support Organization
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $5,287,306 Additional Pipeline Funding: $1,297,200

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,238,241
Care: Orphans and Vulnerable Children (HKID) $263,614
Care: TB/HIV (HVTB) $183,042
Care: Pediatric Care and Support (PDCS) $154,481
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $264,021
Testing: HIV Testing and Counseling (HVCT) $1,100,636
Sexual Prevention: Other Sexual Prevention (HVOP) $22,873
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $267,681
Treatment: Adult Treatment (HTXS) $1,679,214
Treatment: Pediatric Treatment (PDTX) $113,503
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 146
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 282
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 991
GEND_GBV Number of people receiving post-GBV care 2018 1,419
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 593,061
HTS_TST Service Delivery Point (Community) Index Mod: <1, Negative 2018 338
HTS_TST Service Delivery Point (Community) Index Mod: 1-9, Negative 2018 1,909
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Female, Negative 2018 350
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Male, Negative 2018 299
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2018 1
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2018 23
HTS_TST Service Delivery Point (Community) Index Mod: 25-49, Female, Negative 2018 189
HTS_TST Service Delivery Point (Community) Index Mod: 25-49, Male, Negative 2018 111
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Female, Negative 2018 2
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2018 2
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2018 13
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2018 39
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2018 26
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2018 74
HTS_TST Service Delivery Point (Community) Mobile Testing: 25-49, Female, Negative 2018 27
HTS_TST Service Delivery Point (Community) Mobile Testing: 25-49, Male, Negative 2018 64
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative 2018 11
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2018 11
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2018 24,966
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2018 29,110
HTS_TST Service Delivery Point (Facility) ANC: 25-49, Negative 2018 24,966
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2018 4,165
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2018 834
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2018 5,107
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2018 852
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2018 932
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 45
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 3
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 171
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 50
HTS_TST Service Delivery Point (Facility) Index: 25-49, Female, Negative 2018 735
HTS_TST Service Delivery Point (Facility) Index: 25-49, Male, Negative 2018 615
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2018 74
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2018 75
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2018 1,452
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2018 9,760
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2018 1,598
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2018 1,677
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2018 4,124
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2018 588
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2018 13,376
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2018 3,744
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Female, Negative 2018 54,921
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Male, Negative 2018 43,298
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2018 5,456
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2018 5,353
HTS_TST Service Delivery Point (Facility) Malnutrition: Negative 2018 483
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 9,664
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 1,566
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 1,743
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 9,000
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 1,274
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 29,826
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 8,098
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 122,609
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 95,360
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 12,254
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 11,634
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 7,725
HTS_TST Service Delivery Point (Facility) TB: <1, Negative 2018 64
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2018 308
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2018 58
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2018 53
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 4
HTS_TST Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 84
HTS_TST Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 39
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2018 1
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2018 8,534
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2018 9,953
HTS_TST Service Delivery Point (Facility) VMMC: 25-49, Negative 2018 8,534
HTS_TST Service Delivery Point (Facility) VMMC: 50+, Negative 2018 1,423
HTS_TST Service Delivery Point (Facility)Other PITC: <1, Negative 2018 1,507
HTS_TST Sum of Test Result disaggregates 2018 9,727
HTS_TST_POS By Test Result: Positive 2018 9,727
HTS_TST_POS Service Delivery Point (Community) Index Mod: <1, Positive 2018 1
HTS_TST_POS Service Delivery Point (Community) Index Mod: 1-9, Positive 2018 29
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2018 5
HTS_TST_POS Service Delivery Point (Community) Index Mod: 25-49, Female, Positive 2018 125
HTS_TST_POS Service Delivery Point (Community) Index Mod: 25-49, Male, Positive 2018 54
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2018 10
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 25-49, Female, Positive 2018 10
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 25-49, Male, Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2018 212
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2018 235
HTS_TST_POS Service Delivery Point (Facility) ANC: 25-49, Positive 2018 212
HTS_TST_POS Service Delivery Point (Facility) ANC: 50+, Positive 2018 20
HTS_TST_POS Service Delivery Point (Facility) Index: <1, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2018 65
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2018 20
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2018 99
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2018 21
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Female, Positive 2018 442
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Male, Positive 2018 352
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2018 31
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2018 31
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2018 10
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2018 108
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2018 15
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2018 12
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2018 66
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2018 6
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2018 223
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2018 65
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Female, Positive 2018 917
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Male, Positive 2018 736
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2018 97
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2018 90
HTS_TST_POS Service Delivery Point (Facility) Malnutrition: Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) Other PITC: <1, Positive 2018 13
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 102
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 14
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 16
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 138
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 23
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 463
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 131
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 1,941
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 1,555
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 192
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 194
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 78
HTS_TST_POS Service Delivery Point (Facility) TB: 1-9, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 45
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Male, Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) VMMC: 15-19, Positive 2018 65
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2018 176
HTS_TST_POS Service Delivery Point (Facility) VMMC: 25-49, Positive 2018 203
HTS_TST_POS Service Delivery Point (Facility) VMMC: 50+, Positive 2018 18
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 669
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2018 669
OVC_SERV Age/Sex: <1 2018 190
OVC_SERV Age/Sex: 1-9 2018 1,589
OVC_SERV Age/Sex: 10-14 Female 2018 630
OVC_SERV Age/Sex: 10-14 Male 2018 432
OVC_SERV Age/Sex: 15-17 Female 2018 337
OVC_SERV Age/Sex: 15-17 Male 2018 410
OVC_SERV By: Age/sex: 18-24 Female 2018 506
OVC_SERV By: Age/sex: 25+ Female 2018 143
OVC_SERV By: Age/sex: Male 18-24 2018 435
OVC_SERV By: Age/sex: Male 25+ 2018 101
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2018 4,773
OVC_SERV Program Completion: Active 2018 3,605
OVC_SERV Program Completion: Exited without graduation 2018 235
OVC_SERV Program Completion: Graduation 2018 692
OVC_SERV Program Completion: Transferred 2018 241
OVC_SERV Sum of Age/Sex disaggregates 2018 1,809
PMTCT_ART Already on ART at beginning of current pregnancy 2018 1,448
PMTCT_ART New on ART 2018 1,194
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 2,642
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 86,242
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 2,104
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 588
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 1,397
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 35
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 84
PMTCT_STAT By Age (Numerator): 10-14 2018 868
PMTCT_STAT By Age (Numerator): 15-19 2018 16,389
PMTCT_STAT By Age (Numerator): 20-24 2018 16,389
PMTCT_STAT By Age (Numerator): 25-49 2018 52,596
PMTCT_STAT By Number of known positives: 10-14 2018 4
PMTCT_STAT By Number of known positives: 15-19 2018 397
PMTCT_STAT By Number of known positives: 20-24 2018 710
PMTCT_STAT By Number of known positives: 25-49 2018 986
PMTCT_STAT By Number of new negative: 10-14 2018 864
PMTCT_STAT By Number of new negative: 15-19 2018 15,863
PMTCT_STAT By Number of new negative: 20-24 2018 15,451
PMTCT_STAT By Number of new negative: 25-49 2018 51,284
PMTCT_STAT By Number of new positives: 15-19 2018 128
PMTCT_STAT By Number of new positives: 20-24 2018 227
PMTCT_STAT By Number of new positives: 25-49 2018 328
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 86,242
PMTCT_STAT_den By Age (Denominator): <15-19 2018 16,389
PMTCT_STAT_den By Age (Denominator): 10-14 2018 868
PMTCT_STAT_den By Age (Denominator): 20-24 2018 16,389
PMTCT_STAT_den By Age (Denominator): 25-49 2018 52,596
PP_PREV Age/sex: 10-14 Female 2018 110
PP_PREV Age/sex: 10-14 Male 2018 64
PP_PREV Age/sex: 15-19 Female 2018 42
PP_PREV Age/sex: 15-19 Male 2018 26
PP_PREV Age/sex: 20-24 Female 2018 23
PP_PREV Age/sex: 20-24 Male 2018 22
PP_PREV Age/sex: 25-49 Female 2018 86
PP_PREV Age/sex: 25-49 Male 2018 102
PP_PREV Age/sex: 50+ Female 2018 3
PP_PREV Age/sex: 50+ Male 2018 3
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2018 481
PP_PREV Sum of Age/Sex disaggregates 2018 481
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 17
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 269
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 23
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 507
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 860
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 816
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 18
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 284
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 26
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 532
TB_PREV By Age/Sex (Numerator): <15, Female 2018 118
TB_PREV By Age/Sex (Numerator): <15, Male 2018 104
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 2,122
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 1,536
TB_PREV By Therapy type (Numerator): 6-12 Month IPT 2018 3,880
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 3,880
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 7,762
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 278
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 228
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 4,243
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 3,013
TB_PREV_den By Therapy type (Denominator): 6-12 Month IPT 2018 7,762
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 57
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 692
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 76
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,262
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 2,087
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 2,087
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 57
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 692
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 76
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,262
TX_CURR Age/Sex: <1 2018 192
TX_CURR Age/Sex: <1-9 2018 3,063
TX_CURR Age/Sex: 10-14 Female 2018 986
TX_CURR Age/Sex: 10-14 Male 2018 700
TX_CURR Age/Sex: 15-19 Female 2018 682
TX_CURR Age/Sex: 15-19 Male 2018 135
TX_CURR Age/Sex: 20-24 Female 2018 2,154
TX_CURR Age/Sex: 20-24 Male 2018 594
TX_CURR Age/Sex: 25-49 Female 2018 18,922
TX_CURR Age/Sex: 25-49 Male 2018 10,563
TX_CURR Age/Sex: 50+ Female 2018 1,874
TX_CURR Age/Sex: 50+ Male 2018 1,308
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 41,173
TX_CURR Sum of age/sex disaggregates 2018 817
TX_NEW Breastfeeding status 2018 18
TX_NEW By Age/Sex: <1 2018 108
TX_NEW By Age/Sex: 1-9 2018 320
TX_NEW By Age/Sex: 10-14 Female 2018 61
TX_NEW By Age/Sex: 10-14 Male 2018 53
TX_NEW By Age/Sex: 15-19 Female 2018 241
TX_NEW By Age/Sex: 15-19 Male 2018 46
TX_NEW By Age/Sex: 20-24 Female 2018 779
TX_NEW By Age/Sex: 20-24 Male 2018 220
TX_NEW By Age/Sex: 25-49 Female 2018 3,353
TX_NEW By Age/Sex: 25-49 Male 2018 2,763
TX_NEW By Age/Sex: 50+ Female 2018 333
TX_NEW By Age/Sex: 50+ Male 2018 339
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 8,616
TX_NEW Pregnancy status 2018 2,166
TX_NEW Sum of Age/Sex disaggregates 2018 8,188
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 37,061
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 33,351
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 2,198
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 1,796
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 19,150
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 10,207
TX_PVLS Numerator: Indication: Routine 2018 33,351
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 171
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 3,343
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 2,449
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 2,010
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 21,257
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 11,345
TX_PVLS_den Denominator: Indication: Routine 2018 37,061
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 182
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 3,707
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 138
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 119
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 2,145
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1,264
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 3,666
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 4,065
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 138
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 119
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 2,385
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,423
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 41,173
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 824
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 39
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 33
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 477
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 275
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 2,716
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 2,225
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 23,631
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 12,601
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 2,306
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2018 329
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 656
TX_TB_den Denominator: By Screen Result: Negative 2018 37,882
TX_TB_den Denominator: By Screen Result: Positive 2018 3,291
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 3,291
VMMC_CIRC By Age: 10-14 2018 2,627
VMMC_CIRC By Age: 15-19 2018 4,729
VMMC_CIRC By Age: 20-24 2018 6,304
VMMC_CIRC By Age: 25-29 2018 9,983
VMMC_CIRC By Age: 30-49 2018 1,577
VMMC_CIRC By Age: 50+ 2018 1,051
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2018 26,271
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2018 26,271
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2018 14,711
Cross Cutting Budget Categories and Known Amounts Total: $4,269,139
Gender: Gender Based Violence (GBV) $100,000
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Operation Research
Gender: Gender Equality $100,000
Changing harmful gender norms and promoting positive gender norms
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Operation Research
Promoting gender-related policies and laws that increase legal protection
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Operation Research
Increase gender-equitable access to income and productive resources, including education
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Operation Research
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Operation Research
Key Populations: Sex Workers $19,797
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Collection and use of strategic information on SWs and clients
Monitoring and evaluation of SW programs
Renovation $478,321
Human Resources for Health $2,862,691
Motor Vehicles: Purchased $708,330